No menu items!
Saturday, June 7, 2025

cervical

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

Venture Capital Bets on AI for Smarter Investing

Venture capital firms in India are increasingly embracing artificial intelligence (AI) and automation to enhance efficiency in sourcing and...
- Advertisement -spot_img